Atteia et al. demonstrated that the long-term treatment with the sGC stimulator Iisiquiritigenin effectively and dose-dependently improved chronic renal dysfunction and endothelial dysfunction induced by adenine. This evidence concerns the gene SGCB and endothelial dysfunction.